How to influence the loop gain: carbohydrase inhibitors? - 2025 Sleep and Breathing conference

Pharmacotherapy in sleep apnoea: from endophenotypic traits to personalised treatments

Chair(s): Richard Staats, Alan R. Schwartz

Session type: Symposium

How to influence the loop gain: carbohydrase inhibitors?

Jan A. Hedner

EVENTS HOME

Replay
Slides

Previous presentation

Next presentation

Session content

Brain and breathing: what are the targets of drug treatment in OSA and CSA?

Elisa Perger

Replay

Slides

Introduction

Replay

How to influence the loop gain: carbohydrase inhibitors?

Jan A. Hedner

Replay

Slides

Critical appraisal of meta-analysis results on drug treatments

Jean-louis Pépin

Replay

Slides

Discussion and Q&A

Replay

Session aims

- To provide an overview of the endophenotypic traits of sleep apnoea that can be targeted by pharmacotherapy - To present the journey of pharmacotherapy in OSA and CSA, and the way forward - To introduce the place and role of pharmacotherapy in sleep apnoea care pathways, in a personalized therapeutic approach.

CDN Connection Issue

#{title}